CAS RN: 40262-73-5
6-MORPHOLIN-4-YLPYRAZINE-2-CARBOXYLIC ACID
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250730
100mg / 250mg / 1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 40262-73-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
>97%
0
Out of Stock
Hong Kong
Inquiry
40262-73-5 / 6-morpholin-4-ylpyrazine-2-carboxylic acid
Standard CAS: 40262-73-5
Multi CAS: No
Basic Information
copy
CAS
40262-73-5 copy
Multi CAS
No copy
Molecular Formula
C9H11N3O3 copy
Molecular Weight
209.200000 copy
Exact Mass
209.080041 copy
InChI
InChI=1S/C9H11N3O3/c13-9(14)7-5-10-6-8(11-7)12-1-3-15-4-2-12/h5-6H,1-4H2,(H,13,14) copy
InChIKey
UGQVLHNPKAAHDW-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.44 copy
Rotatable bonds
2 copy
H-bond acceptors
5 copy
H-bond donors
1 copy
Molar refractivity
52.02 copy
TPSA
75.55 copy
LogP / Solubility
WLOGP
0.01 copy
MLOGP
0.01 copy
XLogP3
-0.3 copy
Consensus LogP
-0.09 copy
Log S (ESOL)
-1.31 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.28 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.27 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.99 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy